Cart
sales@molnova.com
Thiamine monophosphate chloride dihydrat
CAS No. 273724-21-3
Thiamine monophosphate chloride dihydrat( Aneurine monophosphate chloride )
Catalog No. M19701 CAS No. 273724-21-3
Thiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThiamine monophosphate chloride dihydrat
-
NoteResearch use only, not for human use.
-
Brief DescriptionThiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
-
DescriptionThiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
-
In Vitro——
-
In Vivo——
-
SynonymsAneurine monophosphate chloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number273724-21-3
-
Formula Weight416.82
-
Molecular FormulaC12H22ClN4O6PS
-
Purity>98% (HPLC)
-
SolubilityWater:50mg/mL
-
SMILESO.O.[Cl-].Cc1c(CCOP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stuetz W. Carrara V. McGready R. Lee S. Biesalski H. & Nosten F. (2012). Thiamine Diphosphate in Whole Blood Thiamine and Thiamine Monophosphate in Breast-Milk in a Refugee Population.?Plos ONE?7(6) e36280. doi: 10.1371/journal.pone.0036280
molnova catalog
related products
-
2-AMINO-5-PHENYL-THI...
2-AMINO-5-PHENYL-THIOPHENE-3-CARBOXYLIC is an inhibitior of IKKβ.
-
CFM 4
CFM 4 is a potent small molecule CARP-1/APC-2 antagonist that prevents CARP-1 from binding to APC-2, contributes to G2M cell cycle arrest, and induces apoptosis, with an IC50 in the range of 10-15 μM.
-
Itolizumab
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production.
